Functional Proteomic Profiling Analysis in Four Major Types of Gastrointestinal Cancers
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Gastrointestinal (GI) cancer accounts for one in four cancer cases and one in three cancer-related deaths globally. A deeper understanding of cancer development mechanisms can be applied to cancer medicine. Comprehensive sequencing applications have revealed the genomic landscapes of the common types of human cancer, and proteomics technology has identified protein targets and signalling pathways related to cancer growth and progression. This study aimed to explore the functional proteomic profiles of four major types of GI tract cancer based on The Cancer Proteome Atlas (TCPA). We provided an overview of functional proteomic heterogeneity by performing several approaches, including principal component analysis (PCA), partial least squares discriminant analysis (PLS-DA), t-stochastic neighbour embedding (t-SNE) analysis, and hierarchical clustering analysis in oesophageal carcinoma (ESCA), stomach adenocarcinoma (STAD), colon adenocarcinoma (COAD), and rectum adenocarcinoma (READ) tumours, to gain a system-wide understanding of the four types of GI cancer. The feature selection approach, mutual information feature selection (MIFS) method, was conducted to screen candidate protein signature subsets to better distinguish different cancer types. The potential clinical implications of candidate proteins in terms of tumour progression and prognosis were also evaluated based on TCPA and The Cancer Genome Atlas (TCGA) databases. The results suggested that functional proteomic profiling can identify different patterns among the four types of GI cancers and provide candidate proteins for clinical diagnosis and prognosis evaluation. We also highlighted the application of feature selection approaches in high-dimensional biological data analysis. Overall, this study could improve the understanding of the complexity of cancer phenotypes and genotypes and thus be applied to cancer medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: New Dimensions
Hanahan, D. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1059 · Cited by 9,887
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863 · cited 2×
“Over the past few decades, comprehensive sequencing applications have revealed the genomic landscapes of the common types of human cancer [3].”
BackgroundThe consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170 · cited 1×
“Thus, the COAD and READ cohorts are always considered two subgroups of the entire CRC cohort [20,21], which represents malignant conditions in the lower gastrointestinal tract.”
MethodUsing mutual information for selecting features in supervised neural net learning
Battiti, R. (1994) · IEEE Transactions on Neural Networks · doi:10.1109/72.298224 · Cited by 2,148
Global Burden of 5 Major Types of Gastrointestinal Cancer
Arnold, M., Abnet, C. C., Neale, R. E., Vignat, J., Giovannucci, E. L., McGlynn, K. A., & Bray, F. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.02.068 · Cited by 2,027
Normalized Mutual Information Feature Selection
Estevez, P. A., Tesmer, M., Perez, C. A., & Zurada, J. M. (2009) · IEEE Transactions on Neural Networks · doi:10.1109/tnn.2008.2005601 · Cited by 1,288
Petrelli, F., Cortellini, A., Indini, A., Tomasello, G., Ghidini, M., Nigro, O., Salati, M., Dottorini, L., Iaculli, A., Varricchio, A., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.3520 · Cited by 530 · cited 1×
“In studies of the association between obesity and survival outcomes in cancer patients, the results from large-scale participants indicated that obesity was associated with more mortality overall [41].”
ResultThe regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy
Pavlasova, G., & Mraz, M. (2020) · Haematologica · doi:10.3324/haematol.2019.243543 · Cited by 433
Application of Proteomics in Cancer: Recent Trends and Approaches for Biomarkers Discovery
Kwon, Y. W., Jo, H.-S., Bae, S., Seo, Y., Song, P., Song, M., & Yoon, J. H. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.747333 · Cited by 268
Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas
Rosario, S. R., Long, M. D., Affronti, H. C., Rowsam, A. M., Eng, K. H., & Smiraglia, D. J. (2018) · Nature Communications · doi:10.1038/s41467-018-07232-8 · Cited by 266
A comprehensive genomic pan-cancer classification using The Cancer Genome Atlas gene expression data
Li, Y., Kang, K., Krahn, J. M., Croutwater, N., Lee, K., Umbach, D. M., & Li, L. (2017) · BMC Genomics · doi:10.1186/s12864-017-3906-0 · Cited by 223
Explore, Visualize, and Analyze Functional Cancer Proteomic Data Using the Cancer Proteome Atlas
Li, J., Akbani, R., Zhao, W., Lu, Y., Weinstein, J. N., Mills, G. B., & Liang, H. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0369 · Cited by 124
Identification of a 6-gene signature predicting prognosis for colorectal cancer
Zuo, S., Dai, G., & Ren, X. (2019) · Cancer Cell International · doi:10.1186/s12935-018-0724-7 · Cited by 100
TCPA v3.0: An Integrative Platform to Explore the Pan-Cancer Analysis of Functional Proteomic Data
Chen, M.-J. M., Li, J., Wang, Y., Akbani, R., Lu, Y., Mills, G. B., & Liang, H. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.001260 · Cited by 92
Self-citationWang, A., Liu, H., Yang, J., & Chen, G. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.105208 · Cited by 84
Takahashi, S., Asada, K., Takasawa, K., Shimoyama, R., Sakai, A., Bolatkan, A., Shinkai, N., Kobayashi, K., Komatsu, M., Kaneko, S., et al. (2020) · Biomolecules · doi:10.3390/biom10101460 · Cited by 81
Yin, Q., Chen, W., Zhang, C., & Wei, Z. (2022) · Laboratory Investigation · doi:10.1038/s41374-022-00801-y · Cited by 69
Targeting B-cell non Hodgkin lymphoma: New and old tricks
Solimando, A. G., Ribatti, D., Vacca, A., & Einsele, H. (2016) · Leukemia Research · doi:10.1016/j.leukres.2015.11.001 · Cited by 52
Feature Selection Methods for Protein Biomarker Discovery from Proteomics or Multiomics Data
Shi, Z., Wen, B., Gao, Q., & Zhang, B. (2021) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2021.100083 · Cited by 43
Global Analysis of Microbiota Signatures in Four Major Types of Gastrointestinal Cancer
Wang, J., Wang, Y., Li, Z., Gao, X., & Huang, D. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.685641 · Cited by 41
Self-citationProstate cancer multi-feature analysis using trans-rectal ultrasound images
Mohamed, S., Salama, M. M. A., Kamel, M. S., El-Saadany, E. F., Rizkalla, K. S., & Chin, J. L. (2005) · Physics in Medicine and Biology · doi:10.1088/0031-9155/50/15/n02 · Cited by 36
Kim, G., Kim, N. I., Lee, J. S., Park, M. H., & Kang, K. (2018) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000717 · Cited by 33
Carino, A., Graziosi, L., Marchianò, S., Biagioli, M., Marino, E., Sepe, V., Zampella, A., Distrutti, E., Donini, A., & Fiorucci, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.663771 · Cited by 32
Zhang, Z., Shen, X., Tan, Z., Mei, Y., Lu, T., Ji, Y., Cheng, S., Xu, Y., Wang, Z., Liu, X., et al. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.1053263 · Cited by 23
Somatic Mutations and Intratumoral Heterogeneity of MYH11 Gene in Gastric and Colorectal Cancers
Jo, Y. S., Kim, M. S., Yoo, N. J., et al. (2018) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000484 · Cited by 22
Guo, J., Li, M., Deng, S.-H., Chen, C., Yin, N., Cui, B., & Liu, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.640196 · Cited by 17
The survival impact of surgical therapy in squamous cell carcinoma of the hard palate
Alonso, J. E., Han, A. Y., Kuan, E. C., et al. (2018) · The Laryngoscope · doi:10.1002/lary.27080 · Cited by 17
Oliveira, L., Bergmann, A., de Melo, A. C., et al. (2020) · Medicina oral, patología oral y cirugía bucal · doi:10.4317/medoral.23558 · Cited by 16
Older age impacts on survival outcome in patients receiving curative surgery for solid cancer
Lu, C., Lee, S., Liu, K.-H., et al. (2017) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2017.02.008 · Cited by 15
Qin, X., Zhang, S., Yin, D., et al. (2022) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2022641 · Cited by 14
Li, M., & Zhou, C. (2021) · Translational Cancer Research · doi:10.21037/tcr-21-218 · Cited by 13
After the Genome—A Brief History of Proteomics
Suran, M. (2022) · JAMA · doi:10.1001/jama.2022.7448 · Cited by 11
The Interplay between RNA Editing Regulator ADAR1 and Immune Environment in Colorectal Cancer
Zheng, G., Zhang, G.-J., Zhao, Y., & Zheng, Z. (2023) · Journal of Oncology · doi:10.1155/2023/9315027 · Cited by 11
Identification of gene signatures for COAD using feature selection and Bayesian network approaches
Wang, Y., Gao, X., Ru, X., Sun, P., & Wang, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-12780-7 · Cited by 11
Self-citationWallace, D. S., Zent, C. S., Baran, A. M., Reagan, P. M., Casulo, C., Rice, G., Friedberg, J. W., & Barr, P. M. (2023) · Blood Advances · doi:10.1182/bloodadvances.2022009382 · Cited by 9
Identification of key biomarkers for STAD using filter feature selection approaches
Wang, Y., Wang, J., Hu, Y., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-21760-w · Cited by 8
Self-citationChen, W., Hu, J., He, Y., Liang, Y., Liu, Y., Cheng, Y., Jia, B., Li, X., Yu, G., & Wang, Y. (2022) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-022-04253-4 · Cited by 8
Self-citationCho, D., & Lee, B. (2017) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2017.8037511 · Cited by 7
A Deep Learning-Based Hybrid Feature Selection Approach for Cancer Diagnosis
Wu, H. (2021) · Journal of Physics Conference Series · doi:10.1088/1742-6596/1848/1/012019 · Cited by 6
Peng, J., Xu, H., Chen, Y., Wang, W., Zhu, L., Shao, Y., & Wang, J. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.11.095 · Cited by 3
Self-citationPhan, D. A. T., Duong, T. T., Pham, D. T. N., et al. (2022) · Fetal and Pediatric Pathology · doi:10.1080/15513815.2022.2120786 · Cited by 2
Cited by
Matsuoka, T., & Yashiro, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115880 · Cited by 83
“Likewise, a study characterized by RPPA-based functional proteomic data identified the functional proteome signatures ( MYH11 , CD20 , CHK1_pS345 , AR , PR, HER3 , MYH11 , and SMAD1 ), suggesting that these candidate protein markers can serve as potential prognostic biomarkers in GC [49].”
Background
Metadata
- Authors
- Wang, Y., Gao, X., & Wang, J.
- Affiliations
- Northwestern Polytechnical University (CN)
- Corresponding author
- Gao, Xiaoguang
- Wang, Jihan
- Venue
- Biomolecules
- Publisher
- MDPI AG
- Published
- 2023-04-20
- Volume
- 13
- Issue
- 4
- Pages
- 701
- ISSN
- 2218-273X (ISSN-L)
- PMC
- PMC10135699
- OpenAlex
- W4366691770
- Cited by
- 9
- References
- 41
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 1
- FWCI
- 0.83
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Biomolecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81900134, 2021SF-030, LQ20H160009)
- Shaanxi Provincial Key Research and Development Program (81900134, 2021SF-030, LQ20H160009)
- Natural Science Foundation of Zhejiang Province (81900134, 2021SF-030, LQ20H160009)
- Topics
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- gastrointestinal cancer, esophageal cancer, gastric adenocarcinoma, colon adenocarcinoma, rectal adenocarcinoma, proteomic signatures, mutual information feature selection, tumor progression, cancer prognosis
- MeSH terms
- Adenocarcinoma, Colonic Neoplasms, Humans, Proteins, Genomics, Proteomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.